Corrected: Netherland's Galapagos to spin off innovative medicines unit

Lakefront Biotherapeutics NV

08/01/2025 06:49

(Corrects to say the new company will be named later, not that
it will be named SpinCo, in paragraph 2)
       Jan 8 (Reuters) - Dutch pharmaceutical firm Galapagos
 GLPG.AS  said on Wednesday it was planning to split into two
listed entities by mid-2025, creating a new company focused on
innovative medicines.
    The spin off, to be named at a later date, will be listed on
Euronext following the separation, Galapagos said in a press
release.

 (Reporting by Alban Kacher in Gdansk; editing by Milla Nissi)
 ((alban.kacher@thomsonreuters.com))